Hospitals must notify Medicare patients when care is observation-only

As of March 8, hospitals must alert Medicare patients when they are only under observation care and aren’t being admitted as one of the conditions for facilities to get paid by CMS.

As Kaiser Health News explains, this new requirement, put in place by 2015’s NOTICE Act, may simply “cushion the shock” for patients. Since cost-sharing is higher for Medicare beneficiaries under observation care, the lack of notice may have resulted in surprise bills.

But the standard doesn’t affect care. Medicare still doesn’t cover nursing home care after an observation visit, only after an admission, which CMS had tried, unsuccessfully, to address with the “two-midnight” rule.

“The observation care notice is a step in the right direction, but it doesn’t fix the conundrum some people find themselves in when they need nursing home care following an observation stay,” said Stacy Sanders, federal policy director at the Medicare Rights Center.

Read the full article below: 

""
John Gregory, Senior Writer

John joined TriMed in 2016, focusing on healthcare policy and regulation. After graduating from Columbia College Chicago, he worked at FM News Chicago and Rivet News Radio, and worked on the state government and politics beat for the Illinois Radio Network. Outside of work, you may find him adding to his never-ending graphic novel collection.

Around the web

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Trimed Popup
Trimed Popup